NCT03490396View on ClinicalTrials.gov

Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients

PHASE4TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

November 15, 2019

Study Completion Date

November 15, 2019

Conditions
Oral Mucositis
Interventions
DEVICE

Gelclair

Polyvinylpyrrolidone (PVP) and Sodium Hyaluronate-Containing Oral Gel

COMBINATION_PRODUCT

First® Mouthwash BLM

Viscous Lidocaine, Diphenhydramine, and Aluminum-magnesium Hydroxide/Simethicone Antacid Suspension Mouthwash

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02120

Brigham & Women's Hospital/Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

PharPoint Research, Inc.
All Listed Sponsors
collaborator

PharPoint Research, Inc.

INDUSTRY

lead

Midatech Pharma US Inc.

INDUSTRY

NCT03490396 - Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients | Biotech Hunter | Biotech Hunter